Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-9592 by AstraZeneca for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
AZD-9592 is under clinical development by AstraZeneca and currently in Phase I for Recurrent Head And Neck Squamous Cell Carcinoma....
AZD-9592 by AstraZeneca for Metastatic Colorectal Cancer: Likelihood of Approval
AZD-9592 is under clinical development by AstraZeneca and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
AZD-9592 by AstraZeneca for Non-Small Cell Lung Carcinoma: Likelihood of Approval
AZD-9592 is under clinical development by AstraZeneca and currently in Phase I for Non-Small Cell Lung Carcinoma. According to GlobalData,...
AZD-9592 by AstraZeneca for Solid Tumor: Likelihood of Approval
AZD-9592 is under clinical development by AstraZeneca and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...